Evidence-informed management of chronic low back pain with adjunctive analgesics

Spine Journal

Volumn 8, Issue 1, 2008, Pages 21-27

  Chang, Victor ^a,b   Gonzalez, Peter ^a,b   Akuthota, Venu ^a,b  

^a UNIVERSITY OF COLORADO HOSPITAL   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Chronic low back pain; Neuropathic medications; Nonsurgical therapies; Socioeconomic

Indexed keywords

AMITRIPTYLINE; ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLOMIPRAMINE; DESIPRAMINE; DOXEPIN; DULOXETINE; FELBAMATE; GABAPENTIN; IMIPRAMINE; LAMOTRIGINE; MILNACIPRAN; MIRTAZAPINE; NONSTEROID ANTIINFLAMMATORY AGENT; NORTRIPTYLINE; OXCARBAZEPINE; PARACETAMOL; PHENYTOIN; PLACEBO; PREGABALIN; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TOPIRAMATE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE; ZONISAMIDE;

ADJUVANT THERAPY; AGRANULOCYTOSIS; ANALGESIA; ANOREXIA; ANTICHOLINERGIC EFFECT; APLASTIC ANEMIA; ATAXIA; BLURRED VISION; BREAST CANCER; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; CHRONIC PAIN; COGNITIVE DEFECT; CONSTIPATION; DIABETIC NEUROPATHY; DIARRHEA; DIZZINESS; DOSAGE SCHEDULE COMPARISON; DRUG APPROVAL; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; DRUG WITHDRAWAL; EVIDENCE BASED MEDICINE; EVIDENCE INFORMED MANAGEMENT; FATIGUE; FOOD AND DRUG ADMINISTRATION; HEALTH INSURANCE; HEART ARRHYTHMIA; HEART INFARCTION; HEART MUSCLE CONDUCTION DISTURBANCE; HUMAN; HYPERHIDROSIS; HYPERTENSION; HYPOTENSION; INFECTION; LIVER TOXICITY; LOW BACK PAIN; LOW DRUG DOSE; MAJOR DEPRESSION; MUSCLE WEAKNESS; NAUSEA; NEUROPATHIC PAIN; NOCICEPTION; OFF LABEL DRUG USE; ORTHOSTATIC HYPOTENSION; PAIN ASSESSMENT; PARESTHESIA; PATIENT CODING; PATIENT COMPLIANCE; PERIPHERAL EDEMA; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REIMBURSEMENT; REVIEW; SEDATION; SEIZURE; SEXUAL DYSFUNCTION; SIDE EFFECT; SOMNOLENCE; STEVENS JOHNSON SYNDROME; STROKE; SYSTEMATIC REVIEW; TACHYCARDIA; THEORY; TREATMENT OUTCOME; TRIGEMINUS NEURALGIA; UNSPECIFIED SIDE EFFECT; VERTIGO; VISUAL ANALOG SCALE; VOMITING; WEIGHT GAIN; XEROSTOMIA;

ANALGESICS; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; CHRONIC DISEASE; EVIDENCE-BASED MEDICINE; HUMANS; LOW BACK PAIN;

EID: 37349131249     PISSN: 15299430     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.spinee.2007.10.006     Document Type: Review

References (45)

1. Gorman D.J., Kam P.A., Brisby H., and Diwan A.D. When is spinal pain "neuropathic"?. Orthop Clin North Am 35 (2004) 73-84
2. Goldstein F.J. Adjuncts to opioid therapy. J Am Osteopath Assoc 102 (2002) S15-S21
3. Sindrup S.H., and Jensen T.S. Pharmacologic treatment of pain in polyneuropathy. Neurology 55 (2000) 915-920
4. Wong D.T., Bymaster F.P., and Engleman E.A. Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication. Life Sci 57 (1995) 411-441
5. Gillman P.K. A systematic review of the serotonergic effects of mirtazapine in humans: implications for its dual action status. Hum Psychopharmacol 21 (2006) 117-125
6. Harvey A.T., Rudolph R.L., and Preskorn S.H. Evidence of the dual mechanisms of action of venlafaxine. Arch Gen Psychiatry 57 (2000) 503-509
7. Bymaster F.P., Dreshfield-Ahmad L.J., Threlkeld P.G., et al. Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors. Neuropsychopharmacology 25 (2001) 871-880
8. Muehlbacher M., Nickel M.K., Kettler C., et al. Topiramate in treatment of patients with chronic low back pain: a randomized, double-blind, placebo-controlled study. Clin J Pain 22 (2006) 526-531
9. Rowbotham M., Harden N., Stacey B., Bernstein P., and Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA 280 (1998) 1837-1842
10. Backonja M., Beydoun A., Edwards K.R., et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA 280 (1998) 1831-1836
11. Freynhagen R., Strojek K., Griesing T., Whalen E., and Balkenohl M. Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens. Pain 115 (2005) 254-263
12. Zakrzewska J.M., Chaudhry Z., Nurmikko T.J., Patton D.W., and Mullens E.L. Lamotrigine (lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial. Pain 73 (1997) 223-230
13. Eisenberg E., Lurie Y., Braker C., Daoud D., and Ishay A. Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study. Neurology 57 (2001) 505-509
14. Carrazana E., and Mikoshiba I. Rationale and evidence for the use of oxcarbazepine in neuropathic pain. J Pain Symptom Manage 25 (2003) S31-S35
15. McQuay H., Carroll D., Jadad A.R., Wiffen P., and Moore A. Anticonvulsant drugs for management of pain: a systematic review. BMJ 311 (1995) 1047-1052
16. Staiger T.O., Gaster B., Sullivan M.D., and Deyo R.A. Systematic review of antidepressants in the treatment of chronic low back pain. Spine 28 (2003) 2540-2545
17. Turner J.A., and Denny M.C. Do antidepressant medications relieve chronic low back pain?. J Fam Pract 37 (1993) 545-553
18. van Tulder M.W., Koes B.W., and Bouter L.M. Conservative treatment of acute and chronic nonspecific low back pain. A systematic review of randomized controlled trials of the most common interventions. Spine 22 (1997) 2128-2156
19. Salerno S.M., Browning R., and Jackson J.L. The effect of antidepressant treatment on chronic back pain: a meta-analysis. Arch Intern Med 162 (2002) 19-24
20. Schnitzer T.J., Ferraro A., Hunsche E., and Kong S.X. A comprehensive review of clinical trials on the efficacy and safety of drugs for the treatment of low back pain. J Pain Symptom Manage 28 (2004) 72-95
21. Katz J., Pennella-Vaughan J., Hetzel R.D., Kanazi G.E., and Dworkin R.H. A randomized, placebo-controlled trial of bupropion sustained release in chronic low back pain. J Pain 6 (2005) 656-661
22. McQuay H.J., Tramer M., Nye B.A., Carroll D., Wiffen P.J., and Moore R.A. A systematic review of antidepressants in neuropathic pain. Pain 68 (1996) 217-227
23. Finnerup N.B., Otto M., McQuay H.J., Jensen T.S., and Sindrup S.H. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 118 (2005) 289-305
24. Sindrup S.H., Otto M., Finnerup N.B., and Jensen T.S. Antidepressants in the treatment of neuropathic pain. Basic Clin Pharmacol Toxicol 96 (2005) 399-409
25. Max M.B., Lynch S.A., Muir J., Shoaf S.E., Smoller B., and Dubner R. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 326 (1992) 1250-1256
26. Rowbotham M.C., Reisner L.A., Davies P.S., and Fields H.L. Treatment response in antidepressant-naive postherpetic neuralgia patients: double-blind, randomized trial. J Pain 6 (2005) 741-746
27. Sindrup S.H., Bach F.W., Madsen C., Gram L.F., and Jensen T.S. Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial. Neurology 60 (2003) 1284-1289
28. Yucel A., Ozyalcin S., Koknel T.G., et al. The effect of venlafaxine on ongoing and experimentally induced pain in neuropathic pain patients: a double blind, placebo controlled study. Eur J Pain 9 (2005) 407-416
29. Tasmuth T., Hartel B., and Kalso E. Venlafaxine in neuropathic pain following treatment of breast cancer. Eur J Pain 6 (2002) 17-24
30. Rowbotham M.C., Goli V., Kunz N.R., and Lei D. Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study. Pain 110 (2004) 697-706
31. Detke M.J., Lu Y., Goldstein D.J., Hayes J.R., and Demitrack M.A. Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trial. J Clin Psychiatry 63 (2002) 308-315
32. Detke M.J., Lu Y., Goldstein D.J., McNamara R.K., and Demitrack M.A. Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depression. J Psychiatr Res 36 (2002) 383-390
33. Nemeroff C.B., Schatzberg A.F., Goldstein D.J., et al. Duloxetine for the treatment of major depressive disorder. Psychopharmacol Bull 36 (2002) 106-132
34. Goldstein D.J., Lu Y., Detke M.J., Lee T.C., and Iyengar S. Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain 116 (2005) 109-118
35. Raskin J., Pritchett Y.L., Wang F., et al. A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. Pain Med 6 (2005) 346-356
36. Wernicke J.F., Pritchett Y.L., D'Souza D.N., et al. A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain. Neurology 67 (2006) 1411-1420
37. Lovell J. Carbamazepine and sciatica. Aust Fam Physician 21 (1992) 784-786
38. Khoromi S., Patsalides A., Parada S., Salehi V., Meegan J.M., and Max M.B. Topiramate in chronic lumbar radicular pain. J Pain 6 (2005) 829-836
39. Eisenberg E., Damunni G., Hoffer E., Baum Y., and Krivoy N. Lamotrigine for intractable sciatica: correlation between dose, plasma concentration and analgesia. Eur J Pain 7 (2003) 485-491
40. Dworkin R.H., Backonja M., Rowbotham M.C., et al. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol 60 (2003) 1524-1534
41. Roose S.P., Laghrissi-Thode F., Kennedy J.S., et al. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAMA 279 (1998) 287-291
42. Watson C.P., Evans R.J., Reed K., Merskey H., Goldsmith L., and Warsh J. Amitriptyline versus placebo in postherpetic neuralgia. Neurology 32 (1982) 671-673
43. Dallocchio C., Buffa C., Mazzarello P., and Chiroli S. Gabapentin vs. amitriptyline in painful diabetic neuropathy: an open-label pilot study. J Pain Symptom Manage 20 (2000) 280-285
44. Stahl S.M., Grady M.M., Moret C., and Briley M. SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants. CNS Spectr 10 (2005) 732-747
45. Goldstein D.J., Lu Y., Detke M.J., Hudson J., Iyengar S., and Demitrack M.A. Effects of duloxetine on painful physical symptoms associated with depression. Psychosomatics 45 (2004) 17-28